Asia · Regional markets · CNBC-TV18

Emcure Pharma Q2 Results: Stock jumps 7% after international expansion, domestic momentum drives growth

Published by CNBC-TV18 · India 1 h ago

Emcure Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter stood at ₹587.3 crore, a growth of 23.5% from the year-ago period, while…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Mint

Sebi, investment bankers discuss giving IPO-bound companies more room to revise issue sizes

Tech in Asia

Bridge Data Centres adds new co-CEO to leadership team

Business Standard

Nifty Private Bank index gains 2%; HDFC Bank, ICICI Bank, Axis Bank shine

The Business Times

Singapore speeds up IPO process with listing review functions to be consolidated under SGX RegCo

The Straits Times Business

Listing review process to come fully under SGX RegCo in move to speed up listings

Moneycontrol